British drugmaker AstraZeneca Plc on Friday reported first-quarter product sales and earnings ahead of analysts' expectations, benefiting from higher demand for its cancer medicines.
from Reuters: Company News https://reut.rs/2DD3umJ
via IFTTT
from Reuters: Company News https://reut.rs/2DD3umJ
via IFTTT
Post a Comment